| Financial Year |
March 31 2023 |
| Monetary Funds |
2,034,848,201.15 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,315,667,559.16 |
| Accounts Receivable |
460,845,064.21 |
| Advances to Suppliers |
225,950,293.26 |
| Other Receivables |
45,794,747.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
869,906,945.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,702,823.46 |
| Total Current Assets |
6,268,710,462.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
293,293,247.08 |
| Investment Properties |
22,520,519.78 |
| Fixed Assetes |
10,858,766,548.66 |
| Under-construction Projects |
633,931,311.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
627,556,261.44 |
| R&D expenses |
-- |
| Goodwill |
600,290,362.80 |
| Long-Term Deferred and Prepaid Expenses |
767,889.40 |
| Deferred Income Tax Assets |
152,406,013.95 |
| Other Non-Current Assets |
92,616,433.58 |
| Sub-Total of Non-Current Assets |
13,602,657,093.23 |
| Total Assets |
19,871,367,555.94 |
| Short-Term Loans |
825,422,569.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
766,460,000.00 |
| Accounts Payable |
1,878,452,205.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
204,676,581.48 |
| Taxes Payable |
430,595,605.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
666,103,569.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
89,182,678.55 |
| Other Current Liabilities |
533,265,723.14 |
| Sub-Total of Current Liabilities |
5,888,366,721.79 |
| Long-term Loans |
325,889,182.50 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,057,162.63 |
| Special Payable |
-- |
| Estimatied Liabilities |
66,757,664.27 |
| Deferred Income Tax Liabilities |
233,560,731.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,063,686,298.72 |
| Total Liabilities |
6,952,053,020.51 |
| Paid-In Capital(Or Share Stock) |
1,132,777,625.00 |
| Capital Surplus |
5,697,104,957.46 |
| Surplus Reserve |
157,029,862.73 |
| LESS:Treasury Stock |
115,751,957.00 |
| Undistributed Profits |
4,815,516,635.43 |
| Minority Stockholder's Interest |
1,200,076,588.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,719,237,946.75 |
| Owner's Equity（Stockholder's Equity） |
12,919,314,535.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,871,367,555.94 |
